Giant axonal neuropathy: An updated perspective on its pathology and pathogenesis

Area of Science:

• Neuroscience
• Genetics
• Pathology

Background:

• Giant axonal neuropathy (GAN) is a rare pediatric neurodegenerative disorder.
• Characterized by "giant" axons due to intermediate filament accumulation.
• Progressive disease with onset around age 3 and mortality by the third decade.

Purpose of the Study:

• To analyze reported mutations in the GAN gene.
• To understand the precise mechanisms by which mutations cause GAN.
• To propose a more accurate name reflecting the full disease phenotype.

Main Methods:

• Analysis of all reported mutations in the GAN gene.
• Review of clinical and postmortem pathological findings in GAN patients.
• Comparison of GAN peripheral nerve changes with other neuropathies.

Main Results:

• GAN mutations are distributed throughout the gigaxonin protein structure.
• GAN patients exhibit significant central nervous system signs and degeneration.
• Peripheral nerve pathology resembles Charcot-Marie-Tooth type 2.

Conclusions:

• GAN is a progressive neurodegenerative disease affecting both peripheral and central nervous systems.
• The term "giant axonal neurodegeneration" is proposed to better describe the disease.
• Further research is needed to elucidate the exact molecular mechanisms of GAN pathogenesis.